A Study to Evaluate the Safety, Efficacy and Changes in Induced Sputum and Blood Biomarkers Following Daily Repeat Doses of Inhaled GSK2269557 in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Acute Exacerbation
Clinical trial NCT02522299 · COMPLETED
Trial details
- NCT number
- NCT02522299
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-04
- Primary completion
- 2018-06-15
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.